Outcome of Deferred Initial Therapy in Mantle-Cell LymphomaPeter Martin, John P. Leonard, Maurizio DiLiberto et al.|Journal of Clinical Oncology|2009Cited by 340
Postibrutinib outcomes in patients with mantle cell lymphomaPeter Martin, Kristie A. Blum, Kami J. Maddocks et al.|Blood|2016Cited by 289
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, John P. Leonard, Nancy L. Bartlett et al.|Blood|2019Cited by 84
A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphomaPeter Martin, John P. Leonard, Richard R. Furman et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 27